There is a specific kind of stuck that brings people to my office. The medication is doing something. You are not in the hole you were in a year ago. But you are also not well, and the conversation with your prescriber has narrowed to dose adjustments and switches — a little more, a little less, try this one instead.
Sometimes another medication trial is genuinely the right answer. Often the limiting factor is something the medication was never going to reach. Knowing which situation you are in is the useful skill, so here is how I think about it.
When medication alone is a reasonable plan
Let me be clear about the cases where straightforward pharmacological treatment is appropriate and adding complexity helps nobody:
- A first episode with a clear trigger and a good response. If you started an antidepressant, felt substantially better within six to eight weeks, and are sleeping, eating and functioning, the plan is working. Do not fix it.
- Conditions where medication carries the weight. Bipolar disorder, psychotic illness and severe ADHD are managed primarily pharmacologically. Lifestyle work supports the medication; it does not substitute for it.
- Acute risk. In active suicidality, mania or psychosis, stabilisation comes first and everything else waits.
Six signs a wider assessment is what is missing
1. Partial response that plateaus
You improved 40 or 50 percent and stopped. Two adequate trials at adequate doses have not moved it further. This is the most common pattern in my treatment-resistant depression referrals, and it is where unexamined contributors turn up most often — untreated sleep apnoea, low ferritin, thyroid dysfunction, heavy alcohol use, or a schedule with no daylight and no movement in it.
2. The physical symptoms never lifted
Mood improved but the fatigue, brain fog, or gut symptoms did not. Antidepressants are not designed to correct iron deficiency, hypothyroidism or B12 depletion, all of which produce exactly those residual symptoms.
3. Symptoms track something cyclical
If low mood or anxiety reliably worsens in the luteal phase, escalated after a pregnancy, or arrived alongside perimenopausal changes, the driver is at least partly hormonal. A medication chosen without accounting for that timing is working uphill.
4. You cannot tolerate effective doses
Some people get side effects at doses others do not notice. When several trials have ended in intolerance, a plan that shares the load between a lower medication dose and non-pharmacological components is often more effective than continuing to look for the perfect molecule.
5. Sleep is broken and has stayed broken
Chronic insomnia both mimics and worsens depression and anxiety, and it independently blunts treatment response. If you are six months into medication and still sleeping five hours, treating sleep directly usually produces more improvement than the next dose increase.
6. Nobody has ever checked the basics
If you have never had thyroid function, ferritin, B12 or vitamin D measured during a psychiatric episode, that is not a criticism of your clinician — it is a gap in a system that gives psychiatric visits 15 minutes. It is still worth closing.
What "adding integrative care" actually involves
It does not mean stopping your medication. In most cases the medication management continues unchanged while the assessment widens:
- A structured review of sleep, nutrition, movement, substances and stress load, with one or two specific changes rather than ten vague ones.
- Targeted laboratory work where a result would change the plan, and correction of anything found.
- Where evidence supports it, adjunctive nutrients or mind-body interventions — chosen for your presentation and checked against your prescriptions for interactions.
- Reassessment at a defined interval, so you find out whether it worked rather than accumulating interventions.
Frequently the outcome is that the same medication starts working better, or that a dose can eventually come down. Sometimes the finding is that everything peripheral is already optimised, which is genuinely useful information: it means the next medication decision is the right lever after all.
Questions worth asking your current prescriber
You do not necessarily need to change clinicians to get this. Try:
- "Have we checked thyroid, ferritin, B12 and vitamin D since this episode started?"
- "Could my sleep be a driver rather than a symptom? Should I be screened for apnoea?"
- "Is anything in my other medications contributing to how I feel?"
- "If the next trial does not work either, what is the plan after that?"
A good prescriber will welcome all four. If the answer is that there is no room in the visit to consider them, that is the practical reason people move to an integrative psychiatry practice — not a difference in philosophy, but a difference in how much the appointment can hold.
I see patients across adolescent and adult psychiatry, including addiction and complex medication histories; you can read more about my practice. If you are stuck at partial response, the useful next step is a broader evaluation — not necessarily a different pill.
A worked example
A composite that resembles a great many of my consultations. A woman in her late thirties, two adequate SSRI trials, currently on the second one, describes herself as roughly 50% better: mood is no longer the worst thing, but she is exhausted by mid-afternoon, cannot concentrate through a long meeting, wakes at 4 a.m. most nights, and has been told her bloods were normal.
What a wider assessment turns up in cases like this, in rough order of frequency: heavy periods with a ferritin in the high teens that was never flagged because haemoglobin was fine; a bedtime that has drifted to 1 a.m. with a 6.30 a.m. alarm; two or three glasses of wine most evenings, disclosed only when asked directly; a subclinical thyroid abnormality; occasionally undiagnosed sleep apnoea, particularly where snoring and unrefreshing sleep are present.
The plan that follows is unglamorous: keep the antidepressant, correct the iron over three to six months, move bedtime in twenty-minute increments, cut evening alcohol for a defined trial period, and reassess at eight weeks. Some of these patients then improve substantially without any change to their prescription. Others improve enough that the remaining gap becomes clearly pharmacological — which makes the next medication decision better informed rather than another guess.
FAQs
Should I stop my medication to try an integrative approach?
No — and not without your prescriber. Abruptly stopping psychiatric medication can cause discontinuation symptoms and relapse. Integrative care is normally added alongside existing treatment, and any dose reduction is a later, supervised decision.
How do I know if my antidepressant has had a fair trial?
Generally an adequate trial means a therapeutic dose maintained for six to eight weeks. Improvement that stalls at partial response after two adequate trials is the point at which most guidelines suggest reassessing rather than continuing to switch.
Can vitamin deficiencies really cause depression symptoms?
Deficiencies in iron, B12, folate and vitamin D, and thyroid dysfunction, can all produce fatigue, low mood and cognitive slowing, and can limit response to psychiatric treatment. Correcting them does not replace treating a mood disorder, but leaving them uncorrected makes treatment harder.
Will an integrative psychiatrist take over my prescriptions?
That depends on what you want. Some patients transfer prescribing entirely; others keep their existing prescriber and add a consultative integrative assessment. Either works as long as everyone involved knows the full medication and supplement list.
Is treatment-resistant depression always a medication problem?
Not always. Some cases are genuinely resistant and need pharmacological escalation or interventional options. Others turn out to be under-assessed — undiagnosed sleep disorder, alcohol use, thyroid disease or an unrecognised bipolar-spectrum picture. The distinction matters, because the treatments differ.
